Cross-border deals, innovation and AI: a podcast preview of the East-West Summit

BayHelix’s Guo-Liang Yu and McKinsey’s Olivier Leclerc join the BioCentury This Week podcast to discuss cross-border innovation and deal flow in the biopharma sector and preview the upcoming BioCentury-BayHelix East-West Summit.

Yu, who is the chairman of BayHelix and chairman and CEO of Apollomics Inc. (NASDAQ:APLM), discusses the importance of the event for BayHelix, and Leclerc, a senior partner at McKinsey & Co., previews McKinsey’s second East-West Summit report, which will focus on the impact of AI on the sector.

BioCentury co-founder, President and CEO Dave Flores, Editor in Chief Simone Fishburn, and head of BD Josh Berlin also join the podcast to discuss the importance of globalization for biopharma and patients, the growth of cross-border dealmaking, and panel topics and speakers at the East-West Summit, which takes place Oct. 2-4 in Kendall Square.